Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
14.07
-0.25 (-1.75%)
At close: Sep 11, 2026, 4:00 PM EDT
13.87
-0.20 (-1.42%)
After-hours: Sep 11, 2026, 7:39 PM EDT
Monte Rosa Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 28.73 | 42.95 | 123.67 | 181.54 | 177.99 | 159.49 | 75.62 | 14.98 | 5.76 | 1.06 | - | - | - | - | - | - | - | - | - | - | |
Revenue Growth (YoY) | -83.86% | -73.07% | 63.54% | 1112.27% | 2990.57% | 14889.38% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue | 162.36 | 145.41 | 133.7 | 130.57 | 121.44 | 118.06 | 112.86 | 101.57 | 153.96 | 103.73 | 103.37 | 77.9 | - | 24.56 | - | - | - | - | - | - |
Gross Profit | -133.63 | -102.46 | -10.03 | 50.97 | 56.55 | 41.43 | -37.24 | -86.6 | -148.2 | -102.67 | -103.37 | -77.9 | - | -24.56 | - | - | - | - | - | - |
Selling, General & Admin | 48.22 | 45.82 | 44.18 | 42.46 | 41.59 | 43.56 | 43.87 | 42.38 | 42.75 | 41.33 | 39.94 | 45.97 | 42.39 | 37.82 | 35.12 | 24.96 | 22.69 | 20.5 | 15.73 | 12.54 |
Research & Development | - | - | - | - | - | - | - | - | -51.53 | - | - | 17.07 | 89.94 | 59.97 | 77.26 | 78.32 | 72.1 | 65.18 | 57.16 | 48.89 |
Operating Expenses | 48.22 | 45.82 | 44.18 | 42.46 | 41.59 | 43.56 | 43.87 | 42.38 | -8.78 | 41.33 | 39.94 | 63.03 | 132.33 | 97.79 | 112.38 | 103.28 | 94.79 | 85.68 | 72.88 | 61.43 |
Operating Income | -181.85 | -148.28 | -54.21 | 8.51 | 14.96 | -2.13 | -81.11 | -128.98 | -139.42 | -144 | -143.31 | -140.94 | -132.33 | -122.34 | -112.38 | -103.28 | -94.79 | -85.68 | -72.88 | -61.43 |
Interest & Investment Income | 17.94 | 15.09 | 12.94 | 11.85 | 11.99 | 11.56 | 10.57 | 10.34 | 9.67 | 9.34 | 9.33 | 8.96 | 7.73 | 6.05 | 3.76 | 1.79 | 0.8 | 0.19 | 0.05 | 0.04 |
Currency Exchange Gain (Loss) | -0.06 | 1.3 | 1.48 | 1.54 | 1.41 | -0.03 | 0.42 | -0.37 | -0.19 | -0.23 | -0.93 | -0.43 | -0.4 | -0.17 | 0.01 | 0.23 | 0.18 | -0.25 | -0.16 | -0.15 |
Other Non Operating Income (Expenses) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.96 | -8.64 |
EBT Excluding Unusual Items | -163.97 | -131.88 | -39.78 | 21.9 | 28.37 | 9.4 | -70.13 | -119.01 | -129.93 | -134.89 | -134.91 | -132.42 | -125 | -116.46 | -108.61 | -101.27 | -93.8 | -85.74 | -73.96 | -70.17 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | - | - | - | - | - | -0.13 | -0.13 | -0.13 | -0.13 | - | - | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 0.06 | 0.06 | 0.06 | 0.06 | - | - | - | 0.02 | 0.02 | 0.02 | 0.01 | -0.02 | 0.11 | 0.11 | 0.13 | 0.13 | - | - |
Pretax Income | -163.97 | -131.88 | -39.72 | 21.95 | 28.42 | 9.46 | -70.13 | -119.01 | -129.93 | -134.86 | -135.01 | -132.52 | -125.13 | -116.61 | -108.5 | -101.16 | -93.68 | -85.61 | -73.96 | -70.17 |
Income Tax Expense | -2.86 | -1.87 | -1.1 | 1.01 | 4.26 | 3.31 | 2.57 | 0.38 | 0.48 | 0.42 | 0.34 | 0.36 | 0.19 | - | - | - | - | - | - | - |
Net Income | -161.12 | -130.01 | -38.63 | 20.95 | 24.17 | 6.15 | -72.7 | -119.39 | -130.41 | -135.28 | -135.35 | -132.88 | -125.32 | -116.61 | -108.5 | -101.16 | -93.68 | -85.61 | -73.96 | -70.17 |
Net Income to Common | -161.12 | -130.01 | -38.63 | 20.95 | 24.17 | 6.15 | -72.7 | -119.39 | -130.41 | -135.28 | -135.35 | -132.88 | -125.32 | -116.61 | -108.5 | -101.16 | -93.68 | -85.61 | -73.96 | -70.17 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 92 | 88 | 83 | 82 | 82 | 79 | 74 | 68 | 60 | 54 | 51 | 49 | 49 | 48 | 47 | 47 | 47 | 36 | 25 | 14 |
Shares Outstanding (Diluted) | 92 | 88 | 83 | 83 | 83 | 80 | 74 | 68 | 60 | 54 | 51 | 49 | 49 | 48 | 47 | 47 | 47 | 36 | 25 | 14 |
Shares Change (YoY) | 11.91% | 9.92% | 12.39% | 22.34% | 38.55% | 47.16% | 43.80% | 36.96% | 22.51% | 12.91% | 8.83% | 5.76% | 4.27% | 32.28% | 88.91% | 240.15% | 1769.46% | 2177.87% | 1548.09% | - |
EPS (Basic) | -1.74 | -1.49 | -0.46 | 0.25 | 0.29 | 0.08 | -0.98 | -1.77 | -2.19 | -2.50 | -2.63 | -2.69 | -2.58 | -2.43 | -2.30 | -2.17 | -2.01 | -2.36 | -2.96 | -5.11 |
EPS (Diluted) | -1.74 | -1.50 | -0.46 | 0.25 | 0.29 | 0.08 | -0.98 | -1.77 | -2.19 | -2.50 | -2.63 | -2.69 | -2.58 | -2.43 | -2.30 | -2.17 | -2.01 | -2.36 | -2.96 | -5.11 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -32.08 | -19.66 | -27.5 | 145.02 | 23.85 | 30.48 | 38.01 | -62.79 | -67.76 | -69.81 | -62.84 | -122.02 | -117.66 | -108.87 | -105.38 | -91.38 | -88.93 | -82.15 | -69.1 | -61.62 |
Free Cash Flow Per Share | -0.35 | -0.23 | -0.33 | 1.75 | 0.29 | 0.38 | 0.51 | -0.93 | -1.14 | -1.29 | -1.22 | -2.47 | -2.42 | -2.27 | -2.23 | -1.96 | -1.91 | -2.27 | -2.76 | -4.49 |
Gross Margin | - | -238.54% | -8.11% | 28.08% | 31.77% | 25.98% | -49.25% | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Margin | -633.04% | -345.21% | -43.83% | 4.69% | 8.40% | -1.33% | -107.26% | -861.29% | -2420.91% | -13533.74% | - | - | - | - | - | - | - | - | - | - |
Profit Margin | -560.85% | -302.69% | -31.23% | 11.54% | 13.58% | 3.86% | -96.14% | -797.25% | -2264.53% | -12714.47% | - | - | - | - | - | - | - | - | - | - |
Free Cash Flow Margin | -111.66% | -45.76% | -22.23% | 79.88% | 13.40% | 19.11% | 50.26% | -419.27% | -1176.56% | -6560.62% | - | - | - | - | - | - | - | - | - | - |
EBITDA | -173.73 | -139.94 | -45.85 | 16.84 | 23.3 | 6.14 | -72.99 | -121.07 | -131.78 | -137.03 | -137.09 | -133.09 | -127.69 | -118.2 | -108.64 | -102.2 | -91.76 | -83.07 | -70.75 | -59.89 |
EBITDA Margin | - | - | -37.08% | 9.28% | 13.09% | 3.85% | -96.52% | - | - | - | - | - | - | - | - | - | - | - | - | - |
D&A For EBITDA | 8.13 | 8.34 | 8.36 | 8.33 | 8.34 | 8.27 | 8.12 | 7.91 | 7.64 | 6.97 | 6.22 | 7.85 | 4.65 | 4.14 | 3.75 | 1.08 | 3.03 | 2.61 | 2.13 | 1.55 |
EBIT | -181.85 | -148.28 | -54.21 | 8.51 | 14.96 | -2.13 | -81.11 | -128.98 | -139.42 | -144 | -143.31 | -140.94 | -132.33 | -122.34 | -112.38 | -103.28 | -94.79 | -85.68 | -72.88 | -61.43 |
EBIT Margin | - | - | -43.83% | 4.69% | 8.40% | -1.33% | -107.26% | - | - | - | - | - | - | - | - | - | - | - | - | - |
Effective Tax Rate | - | - | - | 4.59% | 14.97% | 34.97% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |